BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8852035)

  • 1. [The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].
    Nezu M; Oh H; Cho R; Sato H; Ikegami T; Yokota A; Nakaseko C; Nishimura M; Matsuura Y; Morio S; Hiruma K; Nakamura H; Asai T
    Rinsho Ketsueki; 1996 Feb; 37(2):158-60. PubMed ID: 8852035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of vinca alkaloid slow infusion in the treatment of chronic refractory idiopathic thrombocytopenic purpura: a multicenter cooperative study.
    Nomura T; Maekawa T; Uchino H; Miyazaki T; Miura Y; Abe T; Asano S; Kuriya S; Nagai K; Yawata Y
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):98-104. PubMed ID: 2184637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy (CVP) in a patient with refractory idiopathic thrombocytopenic purpura (ITP)].
    Inoue Y; Nakagawa Y; Sawanobori M; Suzuki K; Enomoto H
    Rinsho Ketsueki; 1998 Mar; 39(3):193-7. PubMed ID: 9577642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
    Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective vinca-alkaloid slow infusion therapy of refractory idiopathic thrombocytopenic purpura].
    Wada H; Ata K; Shirato L; Mori H; Sugihara T; Yawata Y
    Rinsho Ketsueki; 1987 Nov; 28(11):1928-34. PubMed ID: 3446865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Refractory immune thrombocytopenic purpura accompanied with avascular necrosis of femoral head receiving the combination of high dose immunoglobulin therapy followed by platelet transfusion could successfully be managed to undergo surgery].
    Katoh M; Shikoshi K; Kosuge T; Umeda M; Tsukahara T
    Rinsho Ketsueki; 1994 Aug; 35(8):798-800. PubMed ID: 7523744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of mitral valve replacement combined with idiopathic thrombocytopenic purpura (ITP)].
    Goshima M; Akiyama K; Koga M; Inoue T; Nemoto M; Negishi N; Sezai Y
    Kyobu Geka; 1999 Jul; 52(7):573-7. PubMed ID: 10402788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine therapy for refractory idiopathic thrombocytopenic purpura.
    Strother SV; Zuckerman KS; LoBuglio AF
    Arch Intern Med; 1984 Nov; 144(11):2198-200. PubMed ID: 6541898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of vinca alkaloids in adult patients with refractory chronic idiopathic thrombocytopenia.
    Sikorska A; Słomkowski M; Marlanka K; Konopka L; Górski T
    Clin Lab Haematol; 2004 Dec; 26(6):407-11. PubMed ID: 15595999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vinca-alkaloid slow infusion therapy in refractory idiopathic thrombocytopenic purpura].
    Endoh N; Wong P; Wakita H; Nakamura H; Sugiura Y; Asai T; Itoh K; Yoshida S
    Rinsho Ketsueki; 1987 Feb; 28(2):194-8. PubMed ID: 3573337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Partial splenic embolization as a preoperative treatment for refractory idiopathic thrombocytopenic purpura].
    Sadamoto Y; Abe Y; Kato K; Nishimura J
    Rinsho Ketsueki; 1998 Dec; 39(12):1194-6. PubMed ID: 10028854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concomitant operation of CABG and splenectomy following high-dose transvenous gamma-globulin therapy in a patient with idiopathic thrombocytopenic purpura--a case report].
    Sato Y; Ishikawa S; Ootaki A; Ootani Y; Takahashi T; Morishita Y
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1222-5. PubMed ID: 7525793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report.
    Gross Z; Rodriguez JJ; Stalnaker BL
    J Reprod Med; 1995 Oct; 40(10):739-42. PubMed ID: 8551481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol.
    Scaradavou A; Bussel J
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):290-5. PubMed ID: 7583383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].
    Asaumi N; Masuda K; Yoshida C; Kiguchi T; Niiya M; Niiya K; Tanimoto M
    Rinsho Ketsueki; 2003 Jul; 44(7):480-2. PubMed ID: 12931570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
    Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
    Litton G
    Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.